Apothecon Pharmaceuticals Pvt. Ltd.

Country/Region: India     State/Province: New Delhi

Main Products: Polyallylamine Hydrochloride 50% Soln., Polyallylamine Hydrochloride 50% Soln.

Location: Padra Jambusar Highway New Delhi Delhi 0, Padra Jambusar Highway

Company Introduction
Our Sevelamer Carbonate goes through a top-notch quality analysis system supervised by skilled quality auditors who assess different products at different level. We have developed a state-of-the-art facility located in New Delhi, Delhi, India, laced with all the required amenities to keep the Sevelamer Carbonate quality consistent and maintained. Buyers can reach us for acquiring first in class Polyallylamine Hydrochloride 50% Soln., as we are enlisted among best in class Exporters since 2000.Entire product line from Apothecon Pharmaceuticals Pvt. ltd. Private Limited are made available in different variations with quality commitments that has no match, making our Sevelamer Carbonate and Polyallylamine Hydrochloride 50% Soln. highly demanded in the international market. Owing to which our export ratio value has reached Below US$1 Million based on Australia,Spain,India,Thailand,United Kingdom market share. Being a quality-conscious entity and a leading Supplier of Sevelamer Carbonate, we make sure that all our products perfectly comply with the laid industry standards and boast supreme quality. This approach throughout our 20 Years of export history led us to acquire US$50 Million - US$100 Million of yearly output.Our professional enterprise was first launched with US$2.5 Million of initial investment under Have Own Export License.
Company Overview

Business Type: Exporter

Business Nature: Exporter

Year Established: 2000, 2000

Legal Status: Have Own Export License

Ownership: Private Limited

Employees: 101 - 200 People

Factory Size: Below 1, 000 square meters

R&D Team Size: 51 - 100 People

Certifications: ISO10012

Contact Information

Contact Person: Binit

Designation: Executive Management

Department: Sales Head

Telephone: 91-8511570131

Business Information

Main Markets: Australia (28%) Spain (27%) United Kingdom (20%) Thailand (18%) India (15%)

Export Focus: Australia, Spain, India, Thailand, United Kingdom

Contract Services: OEM Service Offered

Trade & Financial Information

Annual Revenue: US$50 Million - US$100 Million

Registered Capital: US$2.5 Million

Export Percentage: 91% - 100%

Payment Terms: Bank wire (T/T), Letter of Credit (L/C), MoneyGram, Credit Card (CC)

Product Showcase
Polyallylamine Hydrochloride 50% Soln.
Polyallylamine Hydrochloride 50% Soln.

CL-Link > Health & Medicines in India Health & Medicines in New Delhi Medicines in India Medicines in New Delhi